Russ Berman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Russ berman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Russ Berman Today - Breaking & Trending Today

Eikon Therapeutics Raises $517M, Expands Leadership Team | Business | Jan 2022

Eikon Therapeutics Raises $517M, Expands Leadership Team | Business | Jan 2022
photonics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from photonics.com Daily Mail and Mail on Sunday newspapers.

Daniel Anderson , Barbara Howes , Alfred Bowie Jr , Ben Thorner , Ashish Kheterpal , Russ Berman , Eikon Therapeutics , Alfred Bowie ,

Startup Eikon Therapeutics, headed by Roger Perlmutter, raises $520M for drug discovery using high-resolution protein microscopy

Startup Eikon Therapeutics, headed by Roger Perlmutter, raises $520M for drug discovery using high-resolution protein microscopy
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United States , Abu Dhabi , Abuz Aby , United Arab Emirates , San Francisco , Eric Betzig , Ron Leuty , Alfred Freddie Bowie Jr , Pacific Biosciences , Ashish Kheterpal , Luke Lavis , Russ Berman , Howard Hughes , Dave Goeddel , Barbara Howes , Daniel Anderson , Robert Tijan , Roger Perlmutter , Philip Liang , Xavier Darzacq , University Of California , Merck Research Laboratories , Abu Dhabi Investment Authority , Merck Co , California Inc , Eikon Therapeutics Inc ,

Eikon Therapeutics closes $148M financing to develop super-resolution microscopy


Eikon Therapeutics closes $148M financing to develop super-resolution microscopy
06 May 2021
California-based firm to integrate advanced optics, machine learning with biochemistry; its target application is drug discovery.
Eikon focuses on live-cell super-resolution microscopy for drug discovery.Eikon Therapeutics, a Hayward, California-based company focused on live-cell super-resolution microscopy and engineering for drug discovery, has this week announced that it has closed a $148 million Series A financing round.
The funding is led by The Column Group with participation from Foresite Capital, Innovation Endeavors and Lux Capital. Eikon also announced the appointment of Roger M. Perlmutter, MD, PhD, as its new Chief Executive Officer. ....

United States , Robert Tjian , Eric Betzig , Luke Lavis , Russ Berman , Roger Perlmutter , Rogerm Perlmutter , Xavier Darzacq , Dan Anderson , University Of California , Merck Research Laboratories , Column Group , Eikon Therapeutics , Foresite Capital , Innovation Endeavors , Chief Executive , Nobel Prize , Cell Biology , Merck Research , Interim President , Senior Vice President , Engineering Russ Berman , ஒன்றுபட்டது மாநிலங்களில் , லூக் லாவிஸ் , ரோஜர் பேர்ல்முத்தேர் , டான் ஆண்டர்சன் ,